Adalimumab Biosimilar License-Out Resource

Supply Models :

License-out

CXO(CRO/CMO/CDMO)

NewCo/Co-development

Product NO.211

9-Valent HPV Vaccine License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Clinical Resources

Product NO.210

Anti-Tumor Angiogenesis Peptide Drug License-Out Resource

Supply Models :

License-out

CXO(CRO/CMO/CDMO)

NewCo/Co-development

Product NO.209

Recombinant Protein COVID-19 Vaccine License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Clinical Resources

Product NO.208

Long-Acting GLP-1 Receptor Agonist Peptide Antidiabetic Drug License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Investment & M&A

Product NO.207

Selective JAK1 Inhibitor Anti-Inflammatory Small Molecule Drug License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Clinical Resources

Product NO.206

Third-Generation EGFR Inhibitor Small Molecule Drug License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Investment & M&A

Product NO.205

Liver-Targeted Rare Disease AAV Gene Therapy Pipeline License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Clinical Resources

Product NO.204

Autologous CD19/CD22 Dual-Target CAR-T Cell Therapy License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Clinical Resources

Product NO.203

HER2-Targeted ADC Antibody License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Investment & M&A

Product NO.202

PD-1/CTLA-4 Bispecific Antibody License-Out Resource

Supply Models :

License-out

NewCo/Co-development

Investment & M&A

Product NO.201

Clinical Resources of the Infectious Diseases Department, Tertiary Grade-A Hospital

Supply Models :

License-out

NewCo/Co-development

Clinical Resources

Product NO.200

Submit Requirements